NEVVI Medicare utilization intelligence

← back

IBACH, DANIELMD NPI 1619947876 Clinician

Hematology-Oncology · KNOXVILLE, TN

Specialty Hematology-Oncology — from billed Medicare claims
Trained UNIVERSITY OF TENNESSEE, HSC, COLLEGE OF MEDICINE — medical school, self-reported to CMS
In practice about 32 years since medical school (class of 1994, self-reported to CMS)
Location KNOXVILLE, TN · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 82 codes billed · 268,324 disclosed services (CY2024 — most recent year in data)
Current groups
member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Group affiliation since 2019

20192026
PHYSIOTHERAPY ASSOCIATES INC
2026
TENNESSEE CANCER SPECIALISTS PLLC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2021-03

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J0897 Injection, denosumab, 1 mg
J9299 Injection, nivolumab, 1 mg
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J0185 Injection, aprepitant, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J1437 Injection, ferric derisomaltose, 10 mg
J9263 Injection, oxaliplatin, 0.5 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J1449 Injection, eflapegrastim-xnst, 0.1 mg
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
Q5129 Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg
80053 Blood test, comprehensive group of blood chemicals
36415 Insertion of needle into vein for collection of blood sample
J2405 Injection, ondansetron hydrochloride, per 1 mg
J0461 Injection, atropine sulfate, 0.01 mg
Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
J2919 Injection, methylprednisolone sodium succinate, 5 mg
83615 Lactate dehydrogenase (enzyme) level
J2469 Injection, palonosetron hcl, 25 mcg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96372 Injection of drug or substance under skin or into muscle
82784 Gammaglobulin (immune system protein) measurement
83540 Iron level
82728 Ferritin (blood protein) level
J0640 Injection, leucovorin calcium, per 50 mg
83550 Iron binding capacity
88185 Flow cytometry technique for dna or cell analysis, each additional marker
82607 Cyanocobalamin (vitamin b-12) level
J9190 Injection, fluorouracil, 500 mg
96413 Administration of chemotherapy into vein, 1 hour or less
96375 Injection of additional new drug or substance into vein
82746 Folic acid level, serum
83521 Measurement of immunoglobulin light chains
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J9045 Injection, carboplatin, 50 mg
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J3480 Injection, potassium chloride, per 2 meq
84443 Blood test, thyroid stimulating hormone (tsh)
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
J1200 Injection, diphenhydramine hcl, up to 50 mg
84165 Protein measurement, serum
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J3475 Injection, magnesium sulfate, per 500 mg
82378 Carcinoembryonic antigen (cea) protein level
96415 Administration of chemotherapy into vein, each additional hour
83735 Magnesium level
86334 Immunologic analysis technique on serum (immunofixation)
96417 Administration of additional new drug or substance into vein, 1 hour or less
J7030 Infusion, normal saline solution , 1000 cc
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J3489 Injection, zoledronic acid, 1 mg
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
84153 Psa (prostate specific antigen) measurement, total
96411 Administration of additional new drug or substance into vein using push technique
96360 Infusion into a vein for hydration, 31-60 minutes
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
81002 Urinalysis, manual test
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
84550 Uric acid level, blood
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
36591 Collection of blood sample from implanted device
96374 Injection of drug or substance into vein
96523 Irrigation of implanted venous access drug delivery device
96361 Infusion into a vein for hydration, each additional hour
88184 Flow cytometry technique for dna or cell analysis, first marker
82668 Erythropoietin (protein) level
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
85045 Red blood count, automated test
99195 Drawing of blood for a medical problem
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
83010 Haptoglobin (serum protein) level
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated
82232 Beta-2 microglobulin (protein) level
82270 Stool analysis for blood to screen for colon tumors

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.